Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 2321-2340 of 3,347 trials

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

NCT02243579

This phase II trial studies how well pembrolizumab works in treating patients with stage IB-IVB mycosis fungoides or Sezary syndrome that has returned after a period of improvement or has not responded to at least one type of treatment. Monoclonal antibodies, such as pembrolizumab, may block cancer growth in different ways by targeting certain cells.

Recurrent Mycosis Fungoides and Sezary SyndromeRefractory Mycosis Fungoides and Sezary SyndromeStage IB Mycosis Fungoides and Sezary Syndrome AJCC v7+6 more

National Cancer Institute (NCI)24 participantsStarted Oct 2014

Palo Alto, California, United States • New Haven, Connecticut, United States • Tampa, Florida, United States +5 more locations

COMPLETEDPhase 3< 1 mile

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

NCT01098266

The main objective of the trial is to document the efficacy of NGR-hTNF administered at low dose weekly in advanced Malignant Pleural Mesothelioma patients previously treated with a pemetrexed-based chemotherapy regimen.

Malignant Pleural Mesothelioma

AGC Biologics S.p.A.400 participantsStarted Apr 2010

Corona, California, United States • Duarte, California, United States • Tampa, Florida, United States +46 more locations

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Rheumatoid Arthritis Trials in Other Cities

Dose Dense MVAC for Muscle Invasive Bladder Cancer

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

Validating the MATADOC Against Best Practice Standard External Reference Standard

A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel

Telemedicine Management of Chronic Insomnia

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)

MIS ReFRESH: Robotic vs. Freehand Minimally Invasive Spinal Surgeries

A Study in Moderate to Severe Rheumatoid Arthritis Participants

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

TransForm™ Occlusion Balloon Catheter Registry

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Other Conditions in Philadelphia